CSL Limited

Director, Search & Evaluation Early TA Lead (Haem)

CSL Limited$160K — $200K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Significant tenure in biopharma with a strong focus on external innovation and business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Deep scientific expertise in Haematology is essential.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Established network within biotech, academia, and pharma business development organizations.

Responsibilities

  • Serve as the senior Early Search & Evaluation leader within the Therapeutic Area Leadership Team, influencing strategy.
  • Lead proactive sourcing and scouting for preclinical and Phase 1 assets to build a robust opportunity pipeline.
  • Co-lead internal New Product Opportunity evaluations, advising on advancement decisions.
  • Develop and execute early partnering strategies tailored for priority assets.
  • Drive cross-functional due diligence for opportunities, coordinating assessments across various domains.
  • Collaborate with Business Development to advance high-priority opportunities through negotiation and deal closure.
  • Represent the Therapeutic Area at external events, fostering relationships with biotech and academic communities.

Benefits

  • Hybrid work model, requiring three days onsite at designated R&D hubs.
  • Collaboration with a cross-functional team of experts in the field.
  • Access to specialized conferences and networking opportunities.
  • Involvement in shaping pioneering therapeutic strategies in Haematology.
Full Job Description

We are seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation of external innovation opportunities in the Haematology therapeutic area. Embedded within the Therapeutic Area Leadership Team (TALT), this position will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.

To be hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely.

Main Responsibilities & Accountabilities

  • Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
  • Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy.
  • Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Haematology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.
  • Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.
  • Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.
  • Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.
  • Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.

Qualifications & Experience Requirements

  • Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Must have deep scientific expertise in Haematology.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Strong network within biotech, academia, and pharma BD organizations.

About CSL Limited

CSL Limited is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health. They have a focus on rare and serious diseases, and their products are used in more than 70 countries. CSL Limited was founded in 1916 in Australia, and has since grown to become one of the largest biotech companies in the world. They have a strong commitment to research and development, and invest heavily in new technologies and therapies. CSL Limited is listed on the Australian Securities Exchange and the NASDAQ, and has a market capitalization of over $100 billion.
Learn more about CSL Limited
Size
25,000 employees
Industry
Founded
1904
NASDAQ

Similar Jobs

More Jobs at CSL Limited

More Pharmaceuticals & Biotech Jobs

Find similar Director, Search & Evaluation Early TA Lead (Haem) jobs: